secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K/A
Filed at:   2026-08-20T01:42:34+00:00
Accession:  0001628280-26-058120
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience reverse stock split effective Aug 24, 2026; ticker stays SKYE
-----------------------------------------------------------------------------

- Reverse stock split becomes effective at 12:01 am New York time on August 24, 2026.
- Common stock begins trading split-adjusted on Nasdaq at market open August 24, 2026, under ticker SKYE.
- New CUSIP for post-split common stock is 83086J309.
- Amendment confirms effective date of previously disclosed reverse split; no change to ticker symbol.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026058120/0001628280-26-058120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026058120/skye-20260812.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-058120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer